Singapore Clinical Trial: A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, multi-center study, with a primary efficacy endpoint at 12 weeks, to determine the efficacy, safety, and tolerability of fixed doses of 15 mg bid and 30 mg bid of evenamide as add-on in patients with documented treatment-resistant schizophrenia, which is not adequately controlled by a stable therapeutic dose of the patient’s current antipsychotic medication(s).

Singapore, July 27 -- The Health Sciences Authority received information related to the study titled 'A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, m... और पढ़ें

Singapore Clinical Trial: A Phase 1, 2-Part Study to Determine the Effect of Injection Site on the Relative Bioavailability of a Single Subcutaneous Dose of LY3537031 and to Evaluate the Pharmacokinetics of a Single Intravenous Dose of LY3537031 in Healthy Participants

Singapore, July 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, 2-Part Study to Determine the Effect of Injection Site on the Relative Bioavailability ... और पढ़ें

Singapore Clinical Trial: A Phase 3 Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab Tirumotecan, MK-2870) Followed by Carboplatin/Paclitaxel vs Chemotherapy, Both in Combination With Pembrolizumab as Neoadjuvant Therapy for High-Risk, Early-Stage, Triple-Negative Breast Cancer or Hormone Receptor-low Positive/Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer

Singapore, July 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab... और पढ़ें

Singapore Clinical Trial: A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Firmonertinib Compared with Investigator’s Choice of Osimertinib or Afatinib as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic Non-Small-Cell Lung Cancer with Epidermal Growth Factor Receptor P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations (ALPACCA)

Singapore, July 27 -- The Health Sciences Authority received information related to the study titled 'A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety o... और पढ़ें

Singapore Clinical Trial: A Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MK-2214 in Participants with Early Alzheimer's Disease

Singapore, July 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study to Evaluate the Effic... और पढ़ें

'Modi ji, what happened to your promise?' Rahul Gandhi slams police crackdown on Bihar student protesters

Guwahati, July 27 -- Leader of Opposition in the Lok Sabha Rahul Gandhi on Monday accused the Centre of failing to honour its assurance that no action would be taken against student protesters, allegi... और पढ़ें

Oil Surges Past $100 as Middle East Conflict Rattles Wall Street and Stocks Plunge

Mumbai, July 27 -- Brent oil shot to its highest price since May after increased fighting in the Middle East on Thursday threatened to slow the global flow of crude. At the same time, sharp drops for ... और पढ़ें

MEA conveys "serious concern" to Ukrainian envoy over attacks on commercial vessels after Indian seafarer's death

New Delhi, July 27 -- The Ministry of External Affairs (MEA) on Monday summoned Ukraine's Ambassador to India, Oleksandr Polishchuk, and conveyed India's "serious concern" over recent attacks on comme... और पढ़ें

CWG 2026: Shilpa Shyla upgraded to bronze after Nigerian athlete disqualified in women's shotput F57

Glasgow, July 27 -- Indian para-athlete Shilpa Shyla was upgraded to the bronze medal in the women's shot put F57 event at the 2026 Commonwealth Games after Nigeria's Eucharia Iyiazi was disqualified ... और पढ़ें

CWG 2026: Shilpa Shyla gets bronze after Nigerian athlete disqualified in women's shotput F57

Glasgow, July 27 -- Indian para-athlete Shilpa Shyla won a bronze medal in the women's shot put F57 event at the 2026 Commonwealth Games after Nigeria's Eucharia Iyiazi was disqualified following an o... और पढ़ें

• ««
• «
• 14061
• 14062
• 14063
• 14064
• 14065
• 14066
• 14067
• 14068
• 14069
• 14070
• »
• »»